CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors.
Li J, Huang S, Zhu H, Shou C, Lin T, Yin X, Zhu Q, Sun D, Li X, Shen L, Li J, Kou Y, Zhou Y, Zhang B, Qian H, Yu J, Zhou Y, Tang L, Zhang X.
Li J, et al. Among authors: yu j.
Eur Radiol. 2024 Jun;34(6):3659-3670. doi: 10.1007/s00330-023-10383-y. Epub 2023 Nov 10.
Eur Radiol. 2024.
PMID: 37947835